Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ESNT | CMSA |
|---|---|---|
| Price | $61.09 | $19.48 |
| Change today | ▲ 1.44% | ▲ 0.26% |
| Market cap | $5.49B | $5.49B |
| Return, 3 months | -5.0% | -6.1% |
| Return, year to date | -4.4% | -6.8% |
| Return, 1 year | +3.0% | -14.9% |
| P/E (TTM) | 8.5 | – |
| P/B | 1.0 | – |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.16% | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 34 | 49 |
| 30-day volatility | 29.8% | 10.9% |
| Max drawdown, 1 year | -16.8% | -17.7% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
